Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Azzota Corp AP-26113 DFS Item

Manufacturer:  Azzota Corp C1031

AP-26113 (Brigatinib) is an orally active, potent and selective dual ALK/EGFR inhibitor. AP-26113 binds to and inhibits ALK kinase and ALK fusion proteins as well as EGFR and mutant forms. Please request if need more quantities

Catalog No. 50-161-3050


Add to cart

Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit